For the Fiscal Year Ended Sept. 30
(Dollars in thousands) |
2000
|
1999
|
|
Assets |
|
|
Current Assets |
71,284
|
$59,160
|
Investments |
397,622
|
326,773
|
Assets Whose Use Is Limited |
1,273
|
1,208
|
Property, Plant, and Equipment, net |
215,765
|
210,499
|
Contributions Receivable, less current portion |
16,856
|
15,154
|
Other Assets |
4,758
|
3,848
|
Total Assets |
$707,558
|
$616,642
|
|
Liabilities and Net Assets |
|
|
Current Liabilities |
75,746
|
$66,528
|
Long-Term Debt and Other Liabilities |
150,867
|
154,974
|
Net Assets |
|
|
Unrestricted |
268,854
|
230,048
|
Temporarily Restricted |
131,333
|
92,034
|
Permanently Restricted |
80,758
|
73,058
|
|
Subtotal Net Assets |
480,945
|
395,140
|
Total Liabilities and Net Assets |
$707,558
|
$616,642
|
|
Summary Statistical Information |
|
|
(Unless otherwise noted, includes adult and pediatric patients) |
2000
|
1999
|
Number of Licensed Beds (as of year end) |
27 |
34
|
Adult Inpatient Discharges |
905
|
956
|
Infusion Visits |
43,722
|
34,373
|
Outpatient MD Visits |
74,811
|
69,523
|
Clinical Trials (via Dana-Farber/Harvard Cancer Center) |
397
|
384
|
|
